|
|
|
|
|
|
|
|
|
|
Join us online for Your CDMO Quality Oversight Is Not Working on October 1, 11 AM ET. Explore how sponsors can improve oversight while maintaining strong CDMO partnerships. Our expert panel will share practical strategies for managing deviations, change controls, investigations, technical risks, and accountability. Discover how collaborative, risk-based oversight can improve process performance, strengthen CMC visibility, and help organizations meet regulatory expectations. Register online today.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
By Louis Garguilo, Chief Editor, Outsourced Pharma
|
Would you like a shortcut to failure in regulatory CMC? Hire extensively based on what candidates already know. That’s a provocation underlying a number of conversations with senior leaders in regulatory CMC, and it feels especially relevant to outsourcing. With the correct attitude and leadership, learning (yes, on the job) may beat credentials for long-term success.
|
|
|
|
|
|
|
|
INDUSTRY INSIGHTS CONTINUED
|
|
|
|
|
|
Segments: Next-Generation Tablet Press Technology
|
|
Article | By Todd Martin, Natoli Engineering Company, Inc.
|
Segments increase press output by up to 25% and cut setup time by 88%. Learn the benefits, drawbacks, and manufacturing needs of this rapidly growing tablet press technology.
|
|
|
|
|
|
Our Approach To Regulatory Compliance In Japan
|
|
Article | Curia
|
Japan's pharmaceutical market demands J-DMF registration, Foreign Manufacturer Accreditation, and GMP compliance. Review how experienced CDMO support simplifies PMDA submissions.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
OUTSOURCED PHARMA CAPABILITIES UPDATE
|
|
|
|
|
CDMOs in biologics, cell and gene, and small molecule share their capabilities and available capabilities. See for yourself why this virtual event has become a wildly popular resource to identify options for your development and manufacturing needs.
|
|
|
| Connect With Outsourced Pharma: |
|
|
|
|
